News & Events

Nucleic acid therapeutics in neurodegenerative disorders: emerging technologies and clinical landscape

Nov 09, 2026

In this review, we summarize recent advances in nucleic acid therapeutics, including ASOs, siRNAs, and aptamers, for neurodegenerative disorders such as ALS and Alzheimer’s disease. We discuss chemical engineering, emerging delivery strategies, ongoing clinical trials, and future perspectives for central nervous system targeting.